Discover

CVKD
Cadrenal Therapeutics, Inc. Common Stock
2.17
1 x 2.00
3 x 2.50
bid
ask
+
0.08
3.83%
155 @ 04:00 PM
2.04 -0.13 (5.89%)
Ytd-67.99%
1y-79.89%
2.10
day range
2.38
2.07
52 week range
14.64
Open2.14Prev Close2.09Low2.10High2.38Mkt Cap6.72M
Vol168.42KAvg Vol77.97KEPS-5.63P/E-0.39Forward P/E-3.02
Beta1.73Short Ratio1.17Inst. Own4.75%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-2150-d Avg3.85200-d Avg7.351yr Est35.67
Income Statement
Operating Expenses2.51M
Research and Development Expense771.51K
Selling, General and Administrative Expense1.74M
Operating Income-2.51M
Net Income-2.50M
Net Income Common Stock-2.50M
Net Income Common Stock (USD)-2.50M
Consolidated Income-2.50M
Earnings per Basic Share-1.04
Earnings per Basic Share (USD)-1.04
Earnings per Diluted Share-1.04
Earning Before Interest & Taxes (EBIT)-2.50M
Earning Before Interest & Taxes (USD)-2.50M
Weighted Average Shares2.41M
Weighted Average Shares Diluted2.41M
Balance Sheet
Cash and Equivalents2.31M
Cash and Equivalents (USD)2.31M
Current Assets2.86M
Property, Plant & Equipment Net4.62K
Total Assets2.86M
Current Liabilities1.06M
Total Liabilities1.06M
Accumulated Retained Earnings (Deficit)-41.46M
Shareholders Equity1.80M
Shareholders Equity (USD)1.80M
Assets Non-Current6.79K
Trade and Non-Trade Payables824.81K
Cash Flow
Depreciation, Amortization & Accretion555.00
Net Cash Flow from Financing1.30M
Net Cash Flow / Change in Cash & Cash Equivalents-1.70M
Issuance (Purchase) of Equity Shares1.30M
Net Cash Flow from Operations-3.00M
Share Based Compensation252.36K